81. 先天性副腎皮質酵素欠損症 Congenital adrenal hyperplasia Clinical trials / Disease details

臨床試験数 : 87 / 薬物数 : 87 - (DrugBank : 23) / 標的遺伝子数 : 12 - 標的パスウェイ数 : 68

5 trials found

diseases per page:

Showing 1 to 5 of 5 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05063994 (ClinicalTrials.gov)	December 13, 2021	28/5/2021	Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 ...	A Randomized, Double-Blind, Active-Controlled, Phase 3 Study of Chronocort Compared With Immediate-R ...	Congenital Adrenal Hyperplasia	Drug: Chronocort;Drug: Cortef	Diurnal Limited	NULL	Recruiting	16 Years	N/A	All	150	Phase 3	United States;France;Japan
2	EUCTR2011-005822-23-SE (EUCTR)	18/11/2014	20/09/2013	A trial comparing continuous subcutaneous hydrocortisone infusion (CSHI) therapy with conventional o ...	CONTINUOUS SUBCUTANEOUS HYDROCORTISONE INFUSION IN CONGENITAL ADRENAL HYPERPLASIA	Congenital Adrenal Hyperplasia MedDRA version: 14.1;Level: LLT;Classification code 10010323;Term: Co ...	Trade Name: Solu-Cortef INN or Proposed INN: HYDROCORTISONE SODIUM SUCCINATE Other descriptive name: HY ...	Haukeland University Hospital	NULL	Not Recruiting			Female: yes Male: yes	20	Phase 2	Norway;Sweden
3	NCT02096510 (ClinicalTrials.gov)	August 2014	28/11/2013	Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia ...	Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia ...	Addison Disease;Adrenal Hyperplasia Congenital	Drug: Solu-Cortef;Drug: Cortef	Haukeland University Hospital	NULL	Recruiting	18 Years	65 Years	Both	10	Phase 1/Phase 2	Norway
4	EUCTR2011-005822-23-NO (EUCTR)	16/10/2012	25/02/2013	A trial comparing continuous subcutaneous hydrocortisone therapy with conventional oral glucocortico ...	CONTINUOUS SUBCUTANEOUS HYDROCORTISONE INFUSION IN CONGENITAL ADRENAL HYPERPLASIA	Congenital adrenal hyperplasia (CAH) MedDRA version: 14.1;Level: LLT;Classification code 10010323;Te ...	Trade Name: Solu-Cortef Trade Name: Cortison Trade Name: Prednisolone	Haukeland University Hospital	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Norway
5	NCT00519818 (ClinicalTrials.gov)	August 2007	22/8/2007	Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia	A Phase 2, Open Label, Crossover Pharmacokinetic and Pharmacodynamic Study to Compare Chronocort Ver ...	Congenital Adrenal Hyperplasia;21-Hydroxylase Deficiency;Adrenogenital Syndrome	Drug: Chronocort;Drug: Cortef	Diurnal Limited	National Institutes of Health Clinical Center (CC)	Completed	16 Years	60 Years	All	20	Phase 1/Phase 2	United States

First Previous1Next Last